AGLSL

AGLSL: Members of the Exchange are hereby informed that the trading in Equity Shares of Artemis Global Life Sciences Limited shall be suspended w.e.f. October 24, 2019 (i.e. closing hours of trading on October 23, 2019) on account of Scheme of Amalgamation of Artemis Global Life Sciences Limited with Artemis Medicare Services Limited

Artemis Global Life Sciences Limited has informed the Exchange regarding 'Notice published in the Newspaper - Intimation about the Record Date of the Composite Scheme of Amalgamation between Artemis Global Life Sciences Limited ( Company ), Artemis Health Sciences Limited ( AHSL ), Athena Eduspark Limited ( AEL ) and Artemis Medicare Services Limited ( AMSL ) under Section 230 to 232 of Companies Act 2013 ( Composite Scheme )'.

Artemis Global Life Sciences Limited has informed the Exchange that the Company has fixed Record Date as October 25, 2019 for the purpose of determining the eligibility of the shareholders of the Company to whom equity shares of AMSL will be issued in terms of the Composite Scheme.

Artemis Global Life Sciences Limited has informed the Exchange regarding 'Subject : CORPORATE ANNOUNCEMENTPlease refer to application number 2019/Oct/1269/1289 uploaded on 7th October, 2019 on the website of NEAPS which is attached herewith as Annexure . Please note that the matter relates to PTL Enterprises Limited not the Artemis Global Life Sciences Limited. The Announcement was inadvertently uploaded on the site of NEAPS under the code of AGLSL. This announcement was meant to be uploaded for PTL Enterprises.Further, we have not yet decided the date of Board meeting for AGLSL Once we dec

Artemis Global Life Sciences Limited has informed the Exchange regarding 'Copy of NCLT order in matter of Scheme of Amalgamation of Artemis Heath Sciences Limited, Athena Eduspark Limited, Artemis Global Life Sciences Limited and Artemis Medicare Service Limited'.

Artemis Global Life Sciences Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2019. Further, the company has informed the Exchange regarding voting results.

Artemis Global Life Sciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2019

Artemis Global Life Sciences Limited has informed the Exchange regarding 'Intimation of publication of Notice of 9th Annual General Meeting'.

Artemis Global Life Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2019

Artemis Global Life Sciences Limited has informed the Exchange regarding 'Published financial results for the quarter ended 30.06.2019'.

Artemis Global Life Sciences Limited has submitted to the Exchange, the financial results for the period ended June 30, 2019.

Artemis Global Life Sciences Limited has informed the Exchange regarding Board meeting held on August 14, 2019.

Artemis Global Life Sciences Limited has informed the Exchange regarding 'Newspaper Publication:Pursuant to Regulation 29 read with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 14, 2019, at Gurgaon inter alia, to consider and approve the standalone and consolidated un-audited financial results of the Company for the quarter ended June 30, 2019.The said notice may be accessed on the Company��s website- www.aglsl.in and may

Artemis Global Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Artemis Global Life Sciences Limited has submitted to the Exchange a copy of Compliance under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015.

Artemis Global Life Sciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2019.

Artemis Global Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on May 08, 2019.

The Promoter along with PAC has submitted to the Exchange a copy of Annual Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 as on March 31, 2019.

Artemis Global Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Artemis Global Life Sciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2018.

Artemis Global Life Sciences Limited has informed the Exchange regarding Board meeting held on February 04, 2019.Sub: Outcome of the Board Meeting held on 04th February, 2019Dear Sir/ Madam,In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform you that Board of Directors of the Company in their meeting held on 04.02.2019 have inter alia, considered and approved the un-audited financial results (standalone & consolidated) for the quarter ended 31st December, 2018 as recommended by Audit Committee.Pursuant to Regulation 33 of

Artemis Global Life Sciences Limited has submitted the Exchange a copy Srutinizers report of Court Convened General Meeting held on January 27, 2019. Further, the company has informed the Exchange regarding voting results.Dear Sir/ Madam,With the reference to the captioned matter, we wish to inform you that in accordance with the order dated 19th December, 2018 of the National Company Law Tribunal Bench at New Delhi, meeting of the equity shareholders of the Company and Secured Creditors & Unsecured Creditors of Artemis Medicare Services Limited (Amalgamated Company No. 2) was convened on Sun

Artemis Global Life Sciences Limited has informed the Exchange regarding 'Intimation of Publication of Notice \'.

Artemis Global Life Sciences Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

Artemis Global Life Sciences Limited has submitted to the Exchange a copies of the notice to equity shareholder of Artemis Global Life Sciences Ltd. and notice to secured & unsecured creditor of Artemis Medicare Services Ltd. published in newspapers.

Artemis Global Life Sciences Limited has informed the Exchange regarding�� Disclosure pursuant to Regulation 11, 30 and 37 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015��

Artemis Global Life Sciences Limited has informed the Exchange regarding Dislcosure pursuant to Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirements) Regulation,2015.

Artemis Global Life Sciences Limited has informed the Exchange regarding 'Intimation of Publication of Postal Ballot Notice/Remote E-Voting '.Dear Sir/ Madam,In pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find enclosed herewith a copy of notice published in the following newspapers:-- Business Standard (Naitonal daily newspaper) on December 3, 2018.- Business Standard (Daily newspaper of the State) on December 3, 2018Submitted for your information and records.

Artemis Global Life Sciences Limited has informed the Exchange regarding Notice of Postal BallotSub: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015-Notice of Postal Ballot Dear Sir/ Madam,In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find enclosed herewith a copy of notice of Postal Ballot dated November 27, 2018 being dispatched to shareholders of the Company.The above notice is also uploaded on the website of the Company viz. www.aglsl.in. This is submitted for your informatio

Artemis Global Life Sciences Limited has informed the Exchange regarding 'Sub: Intimation of Cutoff date '.Sub: Intimation of Cutoff date Dear Sir/ Madam,This is further to our letter dated 12th November, 2018 regarding outcome of the Board Meeting held on 12th November, 2018, we further wish to inform you that the company has fixed as 23rd November, 2018 cut-off date for the eligible shareholders to get notice of postal ballot and E-Voting for Seeking authorization of shareholders vide Special Resolution through Postal ballot for the following purpose:a) Continuation of Directorships of Mr. O

Artemis Global Life Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2018.

Artemis Global Life Sciences Limited has informed the Exchange regarding Board meeting held on November 12, 2018.Sub: Outcome of the Board Meeting held on 12th November, 2018Dear Sir/ Madam,In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform you that Board of Directors of the Company in their meeting held on 12th November, 2018 have inter alia approved the following:1. On recommendation of the Audit Committee, the Board of Directors have approved un-audited financial results (standalone & consolidated) of the Company for

Artemis Global Life Sciences Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 14, 2018. Further, the company has informed the Exchange regarding voting results.Sub: Results for 8th Annual General MeetingRef: Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Section 108 of the Companies Act, 2013 and Rule 20(4) of the Companies (Management and Administration) Rules, 2014Dear Sir/ Madam,With the reference to the captioned matter, please note that in the 8th Annual Genernal Meeting of the Compa

Artemis Global Life Sciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 14, 2018Dear Sir/ Madam,Pursuant to Regulation 30, Part-A of Schedule -III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that 8th Annual General Meeting held on 14th September, 2018, Friday at 10:00 AM at Tivoli Garden Resort Hotel, Chhattarpur Hills, Chhattarpur, New Delhi-110074.The meeting concluded at 10.25 AM on the same day.Mr. Onkar S. Kanwar, Chairman chaired the proceeding of the meeting.The Chairman of t

Artemis Global Life Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 14, 2018Sub: Notice of 8th Annual General Meeting and Annual Report of the Company for the Financial Year ending 31st March, 2018 Dear Sir/ Madam,Pursuant to the Regulation 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations , 2015, please find enclosed herewith copy of the Notice of 8th Annual General Meeting (��AGM��) of Artemis Global Life Sciences Limited (��the Company��) schedule to be held on Friday, September 14, 2018 at 10.00

Artemis Global Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on August 03, 2018.

Artemis Global Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on August 03, 2018.Dear Sir/ Madam,In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 we wish to inform you that Board of Directors of the Company in their meeting held on 03.08.2018 have inter alia, considered and approved the un-audited financial results (standalone & consolidated) for the quarter ended 30th June, 2018 as recommended by Audit Committee.Pursuant to Regulation 33 of SEBI (Listing Obligations Disclosure Requirements) Regula

Artemis Global Life Sciences Limited has submitted to the Exchange, the financial results for the period ended June 30, 2018.

Artemis Global Life Sciences Limited has informed the Exchange regarding 'Ref: Submission of financial resultsSub:Regulation 33(3)(b)(i) of SEBI (LODR) Regulation, 2015Dear Sir/ Madam,Pursuant to the Regulation 33(3)(b)(i) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform you that the Company has opted to additionally submit quarterly/year to date consolidated financial results in the first quarter of the financial year 2018-19 and this option will not be changed during the said financial year.This is for your information and records.Thanking you

Artemis Global Life Sciences Limited has submitted to the Exchange a copy of Financial Results for the quarter and year ended March 31, 2018 .(revised)

Artemis Global Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on May 09, 2018.

Artemis Global Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on May 09, 2018.Dear Sir/ Madam,We wish to inform you that Board of Directors of the Company in their meeting held on 09.05.2018 have inter alia approved the following:1. On recommendation of the Audit Committee, the Board of Directors has approved audited financial results (standalone & consolidated) of the Company under Indian Accounting Standards (IND AS) for the quarter/ year ending March 31, 2018.Pursuant to Regulation 33 of SEBI (Listing Obligations Disclosure Requirements) Regulations,

Artemis Global Life Sciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2018.

Onkar S. Kanwar has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Artemis Global Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on February 05, 2018.

Artemis Global Life Sciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2017.

Artemis Global Life Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2017.

Artemis Global Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on October 31, 2017.In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 we wish to inform you that Board of Directors of the Company in their meeting held on 31.10.2017 have inter alia, considered and approved the unaudited financial results for the quarter and half year ended 30th September, 2017 as recommended by Audit Committee.Further Pursuant to Regulation 33 of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015, a co

Artemis Global Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Artemis Global Life Sciences Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 27, 2017. Further, the company has informed the Exchange regarding voting results.